What's breaking now, across thousands of outlets.
The state ordered the crypto ATM company to pay $4.8 million to scam victims, and bashed federal regulators over failing to police for fraud.
We haven't written up this one. Payments Dive has the full story — the link below goes straight to it.
Gene therapy demand stabilizes while siRNA readouts and FDA talks loom ahead.
Going concern warning removed as revenue jumps and guidance rises again.
Record net new ARR and a retention milestone shaped the quarter.
Strong royalties and pipeline progress, but litigation risks remain in focus.
The first acquisition adds recurring revenue as cash stays strong.
Steady and reliably growing dividends are just the start of this REIT's appeal.